XML 22 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statement of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
OPERATING ACTIVITIES      
Net income $ 6,865,000 $ 7,180,000 $ 7,028,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Provision for loan losses 315,000 370,000 196,000
Investment securities gains, net (323,000) (248,000) (11,000)
Depreciation and amortization 1,013,000 1,049,000 891,000
Amortization of premium and discount on investment securities 669,000 737,000 1,100,000
Accretion of deferred loan fees, net (603,000) (237,000) (245,000)
Origination of loans held for sale (17,889,000) (6,223,000)  
Proceeds from sale of loans held for sale 17,549,000 6,022,000  
Gains on sale of loans (329,000) (237,000)  
Earnings on bank-owned life insurance (624,000) (276,000) (280,000)
Deferred income taxes 558,000 (154,000) 423,000
Stock-based compensation expense 18,000 10,000  
(Gain) loss on other real estate owned (48,000) 183,000 18,000
Other real estate owned writedowns 102,000 123,000 101,000
(Increase) decrease in accrued interest receivable (292,000) 40,000 28,000
Increase (decrease) in accrued interest payable 80,000 (49,000) (128,000)
Decrease in prepaid federal deposit insurance     513,000
Other, net 121,000 (831,000) 263,000
Net cash provided by operating activities 7,182,000 7,459,000 9,897,000
Investment securities available for sale:      
Proceeds from repayments and maturities 13,497,000 13,474,000 25,411,000
Proceeds from sale of securities 15,686,000 8,383,000 25,088,000
Purchases (21,946,000) (12,287,000) (25,815,000)
Increase in loans, net (63,937,000) (36,222,000) (29,829,000)
Proceeds from the sale of other real estate owned 1,762,000 832,000 882,000
Purchase of bank-owned life insurance (4,000,000)    
Purchase of premises and equipment (507,000) (902,000) (1,834,000)
Net cash used for investing activities (59,445,000) (26,722,000) (6,097,000)
FINANCING ACTIVITIES      
Net increase (decrease) in deposits 38,335,000 17,276,000 (24,499,000)
Increase in short-term borrowings, net 21,017,000 3,999,000 4,271,000
Repayment of other borrowings (685,000) (985,000) (1,361,000)
Common stock issued     74,000
Stock options exercised (7,000) (50,000) (77,000)
Proceeds from dividend reinvestment and purchase plan 651,000 590,000 736,000
Purchase of treasury stock (6,784,000)    
Cash dividends (2,153,000) (2,121,000) (2,097,000)
Net cash provided by (used for) financing activities 50,374,000 18,709,000 (22,953,000)
Decrease in cash and cash equivalents (1,889,000) (554,000) (19,153,000)
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR 25,639,000 26,193,000 45,346,000
CASH AND CASH EQUIVALENTS AT END OF YEAR 23,750,000 25,639,000 26,193,000
Cash paid during the year for:      
Interest on deposits and borrowings 3,740,000 4,119,000 5,378,000
Income taxes 800,000 2,260,000 1,620,000
Non-cash investing transactions:      
Transfers from loans to other real estate owned 638,000 $ 1,030,000 2,113,000
Loans to facilitate the sale of other real estate owned     $ (260,000)
Death benefit proceeds not yet received from insurance company $ 575,000